Nutrien Ltd. (TSE:NTR - Get Free Report) Senior Officer Mark Thompson acquired 245 shares of Nutrien stock in a transaction that occurred on Wednesday, June 25th. The stock was acquired at an average cost of C$81.30 per share, with a total value of C$19,918.50.
Mark Thompson also recently made the following trade(s):
- On Friday, May 9th, Mark Thompson purchased 220 shares of Nutrien stock. The stock was purchased at an average cost of C$76.61 per share, for a total transaction of C$16,854.20.
- On Monday, March 31st, Mark Thompson bought 400 shares of Nutrien stock. The stock was acquired at an average cost of C$71.18 per share, for a total transaction of C$28,472.00.
Nutrien Stock Performance
Shares of NTR stock traded down C$1.07 on Wednesday, hitting C$80.50. The company's stock had a trading volume of 1,703,645 shares, compared to its average volume of 1,753,402. Nutrien Ltd. has a fifty-two week low of C$60.74 and a fifty-two week high of C$88.03. The stock's 50 day moving average is C$79.98 and its 200-day moving average is C$74.33. The company has a market capitalization of C$27.71 billion, a PE ratio of 37.90, a PEG ratio of 1.15 and a beta of 0.95. The company has a debt-to-equity ratio of 59.10, a quick ratio of 0.65 and a current ratio of 1.27.
Nutrien Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 18th. Investors of record on Monday, June 30th will be given a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.71%. Nutrien's dividend payout ratio is 137.48%.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the company. Raymond James Financial cut Nutrien from a "moderate buy" rating to a "hold" rating in a research report on Tuesday, June 17th. BNP Paribas raised Nutrien to a "strong-buy" rating in a research note on Wednesday, April 9th. The Goldman Sachs Group raised shares of Nutrien to a "strong sell" rating in a research report on Thursday, March 13th. Finally, Scotiabank cut shares of Nutrien from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, May 14th. One analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold".
Check Out Our Latest Report on NTR
About Nutrien
(
Get Free Report)
Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrientsnitrogen, potash, and phosphatealthough its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.